Human papillomaviruses (HPVs) have been identified in 99% of cervical tumors. Considerable speculation exists about the role of HPV in cancer at other sites, such as skin, esophagus, and lung. One barrier to the study of HPV in extragenital tumors may be the inability to detect novel HPV types. Our objective was to design broad-range primers for detecting papillomaviruses from any group in the HPV...
Financed by the National Centre for Research and Development under grant No. SP/I/1/77065/10 by the strategic scientific research and experimental development program:
SYNAT - “Interdisciplinary System for Interactive Scientific and Scientific-Technical Information”.